The Bottom Line: NeuroSense (NASDAQ: NRSN)* is on the verge of potentially transforming ALS treatment with PrimeC, a novel drug combo showing remarkable 36% reduction in disease progression and 43%…
Posts published in “Wall Street Wire”
Silexion Therapeutics Corp. (NASDAQ: SLXN)* recently released its full-year 2024 financial results and business update, showcasing remarkable progress in its clinical and preclinical programs targeting KRAS-driven cancers. Following these developments,…
Actelis Networks (NASDAQ: ASNS)*, a leader in cyber-hardened networking solutions, continues to strengthen its position in the critical infrastructure sector with its recent announcement of a new order from one…
Palatin Technologies’ (NYSE: PTN)* Oral MC4R Agonist Gets FDA Orphan Drug Status; Phase 2 Results in Drug Targeting $44 Billion Obesity Market Expected Any Day According to the Company, alongside…
In a market where institutional capital is scarce for small-cap companies, Beyond Oil Ltd.* (CSE: BOIL | OTCQB: BEOLF | Frankfurt: UH9) has achieved what few can—securing a C$10.5 million…
DarioHealth Corp. (Nasdaq: DRIO)* announced its fourth quarter and full-year 2024 financial results today, surpassing analyst expectations and demonstrating remarkable growth in its business-to-business-to-consumer (B2B2C) segment. The digital health company,…
In a significant move for the food-tech sector, Beyond Oil Ltd. has received global supplier approval from Restaurant Brands International (RBI), allowing its patented oil filtration system to be offered…
A newly published study from the Cleveland Clinic’s Lerner Research Institute has added to the growing body of evidence supporting Nuvectis Pharma’s (NASDAQ: NVCT)* NXP900, a novel SRC/YES1 kinase inhibitor.…
Laurel Eastman believes an Israeli innovation could dramatically improve food safety in the U.S. and is pushing for its widespread adoption. As the president of Latitude and a former senior…
In a major development that could reshape how blood is monitored during surgical procedures, Inspira Technologies has revealed that its HYLA blood sensor achieved 96% accuracy in a key parameter…